Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan vs Olmesartan in Chinese Patients with Essential Hypertension
NCT02407210Phase 3Unknown
- Sponsor
- Hengrui
- Start
- Jan 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azilsartan in essential hypertension, sponsored by Hengrui. Status: unknown.
02
Drugs
azilsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02407210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02407210.